Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...

The convergence of front-end and back-end processes in advanced packaging is reshaping the industry. The semiconductor ...

NH Business Review will honor more than 50 businesses throughout the Granite State during its 18 th annual Best of Business ...

Venezuelans with temporary legal protections have sued the Trump administration over its decision to strip about 350,000 ...